Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

[Psychopharmacology of autism spectrum disorders].

Poustka L, Banaschewski T, Poustka F.

Nervenarzt. 2011 May;82(5):582-9. doi: 10.1007/s00115-010-3238-7. Review. German.

PMID:
21484169
2.

Psychopharmacology of autistic spectrum disorders in children and adolescents.

Nazeer A.

Pediatr Clin North Am. 2011 Feb;58(1):85-97, x. doi: 10.1016/j.pcl.2010.10.011. Review.

PMID:
21281850
3.

Psychopharmacology in childhood disorders.

Wiener JM.

Psychiatr Clin North Am. 1984 Dec;7(4):831-43. Review.

PMID:
6151651
4.

[Autism and ADHD across the life span. Differential diagnoses or comorbidity?].

Banaschewski T, Poustka L, Holtmann M.

Nervenarzt. 2011 May;82(5):573-80. doi: 10.1007/s00115-010-3239-6. Review. German.

PMID:
21484168
5.

Pharmacotherapy of irritability in pervasive developmental disorders.

Stigler KA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002. Review.

PMID:
18775367
6.
8.

Managing irritability and aggression in autism spectrum disorders in children and adolescents.

Robb AS.

Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Review.

PMID:
20981764
9.

Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.

Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B.

J Abnorm Child Psychol. 2008 Jan;36(1):117-28. Epub 2007 Aug 3.

PMID:
17674186
10.

Psychopharmacology of autism spectrum disorders: a selective review.

Mohiuddin S, Ghaziuddin M.

Autism. 2013 Nov;17(6):645-54. doi: 10.1177/1362361312453776. Epub 2012 Aug 14. Review.

PMID:
22892891
11.
12.

Treatment of adult ADHD and comorbid disorders.

Young JL.

CNS Spectr. 2006 Oct;11(10 Suppl 11):10-2. No abstract available.

PMID:
17712918
13.

[Pharmacological treatments in patients with pervasive developmental disorders: A review].

Béhérec L, Quilici G, Rosier A, Gerardin P, Campion D, Guillin O.

Encephale. 2014 Apr;40(2):188-96. doi: 10.1016/j.encep.2012.01.014. Epub 2013 Dec 23. Review. French.

PMID:
24369879
14.
15.

Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.

Malone RP, Gratz SS, Delaney MA, Hyman SB.

CNS Drugs. 2005;19(11):923-34. Review.

PMID:
16268664
16.

Pharmacological management in children and adolescents with pervasive developmental disorder.

Sung M, Fung DS, Cai Y, Ooi YP.

Aust N Z J Psychiatry. 2010 May;44(5):410-28. doi: 10.3109/00048670903493330.

PMID:
20047454
17.

Mental illness and addiction issue brief: psychotropic medication and children: year end report-2004.

Rosenberg M.

Issue Brief Health Policy Track Serv. 2004 Dec 31:1-7. No abstract available.

PMID:
15744950
18.

Pharmacotherapy and children with autism spectrum disorder: a tutorial for speech-language pathologists.

Self TL, Hale LS, Crumrine D.

Lang Speech Hear Serv Sch. 2010 Jul;41(3):367-75. doi: 10.1044/0161-1461(2009/08-0106). Epub 2010 Jun 11.

PMID:
20543026
19.
20.

Pharmacotherapy of autism spectrum disorders.

Benvenuto A, Battan B, Porfirio MC, Curatolo P.

Brain Dev. 2013 Feb;35(2):119-27. doi: 10.1016/j.braindev.2012.03.015. Epub 2012 Apr 25. Review.

PMID:
22541665

Supplemental Content

Support Center